Schilling Christopher T.
Officer · ARMK
As of 2026-09-16, Schilling Christopher T. has 14 Form 4 transactions on record across 1 company — 10 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
- Direct $2.3M
- Indirect $0
| ARMK | direct | 40,430 sh | $2.3M |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|
14 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-09-09 | ARMK | Award / grant | 33 | 40,430 | Form 4 |
| 2026-06-03 | ARMK | Award / grant | 35 | 40,397 | Form 4 |
| 2026-03-04 | ARMK | Award / grant | 45 | 40,362 | Form 4 |
| 2025-12-17 | ARMK | Award / grant | 49 | 40,316 | Form 4 |
| 2025-12-02 | ARMK | Withheld for tax | 338 | 40,267 | Form 4 |
| 2025-12-01 | ARMK | Award / grant | 4,315 | 40,605 | Form 4 |
| 2025-12-01 | ARMK | Award / grant | 7,705 | 7,705 | Form 4 |
| 2025-11-27 | ARMK | Withheld for tax | 492 | 36,290 | Form 4 |
| 2025-11-17 | ARMK | Withheld for tax | 481 | 36,782 | Form 4 |
| 2025-11-10 | ARMK | Award / grant | 3,809 | 37,263 | Form 4 |
| 2025-08-20 | ARMK | Award / grant | 29 | 33,451 | Form 4 |
| 2025-05-28 | ARMK | Award / grant | 29 | 33,422 | Form 4 |
| 2025-02-24 | ARMK | Award / grant | 31 | 33,392 | Form 4 |
| 2024-12-12 | ARMK | Award / grant | 29 | 33,361 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.